Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers.
Dina M K El GindyMohamed H SolaymanRamy KhorshidMona F SchaalanLamia Mohamed El WakeelPublished in: Cardiovascular drugs and therapy (2022)
GRK5 rs2230345 T-allele carriers were less responsive than AA genotype carriers to prophylactic beta-blockers for the prevention of POAF after CABG. The study was registered on http://clinicaltrials.gov in March 2019, with trial registration number (TRN): NCT03871647.
Keyphrases
- coronary artery bypass grafting
- percutaneous coronary intervention
- coronary artery disease
- atrial fibrillation
- angiotensin converting enzyme
- acute coronary syndrome
- study protocol
- clinical trial
- genome wide
- heart failure
- phase iii
- cancer therapy
- left atrial
- angiotensin ii
- randomized controlled trial
- oral anticoagulants
- phase ii
- dna methylation
- drug delivery
- left ventricular
- mitral valve